aluates Reports

$ 0.0

Automative

Global Immunotherapy Products Market Research Report 2026

Published Date: 2026-01-28

Report Code: QYRE-Auto-7C20368

BUY CHAPTERS

Global Immunotherapy Products Market Research Report 2026

Code: QYRE-Auto-7C20368

Report

2026-01-28

Pages:142

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Immunotherapy Products Market Size

The global Immunotherapy Products market was valued at US$ 264300 million in 2025 and is anticipated to reach US$ 396410 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Immunotherapy Products Market

Immunotherapy products refer to a broad class of biopharmaceuticals that prevent or treat diseases by activating, suppressing, or modulating the human immune system. This category includes therapeutic and prophylactic vaccines, antibody therapeutics, antibody-drug conjugates (ADCs), cell therapies such as CAR-T, peptide therapeutics, and various immunomodulators, with major applications in oncology, autoimmune and inflammatory diseases, and selected infectious diseases. From an industry perspective, immunotherapy is characterized by high technological barriers, long development cycles, and stringent regulatory requirements, but also by strong pricing power and relatively long commercial lifecycles once products are approved. On the supply side, the average gross margin of leading global companies' immunotherapy-related businesses in 2025 is generally estimated to be in the range of approximately 65%–80%, with variations driven by modality mix, manufacturing strategy (in-house versus outsourced), competitive intensity, and regional pricing dynamics.

The North American market for Immunotherapy Products is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Immunotherapy Products is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Immunotherapy Products in Hospitals and Clinical Healthcare Institutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Immunotherapy Products include Johnson & Johnson, Roche, Pfizer, Merck, AbbVie, Novartis, Bristol Myers Squibb, Sanofi, AstraZeneca, Takeda, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Immunotherapy Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immunotherapy Products. The Immunotherapy Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Immunotherapy Products market comprehensively. Regional market sizes by Type, by Application, by Mode, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Immunotherapy Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Immunotherapy Products Market Report

Report Metric	Details
Report Name	Immunotherapy Products Market
Accounted market size in 2025	US$ 264300 million
Forecasted market size in 2032	US$ 396410 million
CAGR	5.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Therapeutic and Prophylactic Vaccines Cell Therapy Antibody Therapeutics Antibody-Drug Conjugates Peptide Therapeutics and Peptide Conjugates Immunomodulators
Segment by Mode	Immune-Activating Interventions Immune-Suppressive / Immune-Tolerant Interventions Immune Reconstitution and Balancing Interventions
Segment by Diseases	Oncology Autoimmune and Inflammatory Diseases Infectious Disease Prevention and Treatment Other
Segment by Application	Hospitals and Clinical Healthcare Institutions Research Institutes and Academic Laboratories Biopharmaceutical and Biotechnology Companies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Roche, Pfizer, Merck, AbbVie, Novartis, Bristol Myers Squibb, Sanofi, AstraZeneca, Takeda, Amgen, Eli Lilly, Gilead Sciences, Novo Nordisk, GlaxoSmithKline, CSL, UCB, Moderna, BioNTech, BeiGene, Innovent Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Mode, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Immunotherapy Products companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Immunotherapy Products Market growing?

Ans: The Immunotherapy Products Market witnessing a CAGR of 5.9% during the forecast period 2026-2032.

What is the Immunotherapy Products Market size in 2032?

Ans: The Immunotherapy Products Market size in 2032 will be US$ 396410 million.

Who are the main players in the Immunotherapy Products Market report?

Ans: The main players in the Immunotherapy Products Market are Johnson & Johnson, Roche, Pfizer, Merck, AbbVie, Novartis, Bristol Myers Squibb, Sanofi, AstraZeneca, Takeda, Amgen, Eli Lilly, Gilead Sciences, Novo Nordisk, GlaxoSmithKline, CSL, UCB, Moderna, BioNTech, BeiGene, Innovent Biologics

What are the Application segmentation covered in the Immunotherapy Products Market report?

Ans: The Applications covered in the Immunotherapy Products Market report are Hospitals and Clinical Healthcare Institutions, Research Institutes and Academic Laboratories, Biopharmaceutical and Biotechnology Companies, Other

What are the Type segmentation covered in the Immunotherapy Products Market report?

Ans: The Types covered in the Immunotherapy Products Market report are Therapeutic and Prophylactic Vaccines, Cell Therapy, Antibody Therapeutics, Antibody-Drug Conjugates, Peptide Therapeutics and Peptide Conjugates, Immunomodulators

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunotherapy Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Therapeutic and Prophylactic Vaccines

1.2.3 Cell Therapy

1.2.4 Antibody Therapeutics

1.2.5 Antibody-Drug Conjugates

1.2.6 Peptide Therapeutics and Peptide Conjugates

1.2.7 Immunomodulators

1.3 Market by Mode

1.3.1 Global Immunotherapy Products Market Size Growth Rate by Mode: 2021 vs 2025 vs 2032

1.3.2 Immune-Activating Interventions

1.3.3 Immune-Suppressive / Immune-Tolerant Interventions

1.3.4 Immune Reconstitution and Balancing Interventions

1.4 Market by Diseases

1.4.1 Global Immunotherapy Products Market Size Growth Rate by Diseases: 2021 vs 2025 vs 2032

1.4.2 Oncology

1.4.3 Autoimmune and Inflammatory Diseases

1.4.4 Infectious Disease Prevention and Treatment

1.4.5 Other

1.5 Market by Application

1.5.1 Global Immunotherapy Products Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Hospitals and Clinical Healthcare Institutions

1.5.3 Research Institutes and Academic Laboratories

1.5.4 Biopharmaceutical and Biotechnology Companies

1.5.5 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Immunotherapy Products Market Perspective (2021–2032)

2.2 Global Immunotherapy Products Growth Trends by Region

2.2.1 Global Immunotherapy Products Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Immunotherapy Products Historic Market Size by Region (2021–2026)

2.2.3 Immunotherapy Products Forecasted Market Size by Region (2027–2032)

2.3 Immunotherapy Products Market Dynamics

2.3.1 Immunotherapy Products Industry Trends

2.3.2 Immunotherapy Products Market Drivers

2.3.3 Immunotherapy Products Market Challenges

2.3.4 Immunotherapy Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immunotherapy Products Players by Revenue

3.1.1 Global Top Immunotherapy Products Players by Revenue (2021–2026)

3.1.2 Global Immunotherapy Products Revenue Market Share by Players (2021–2026)

3.2 Global Top Immunotherapy Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Immunotherapy Products Revenue

3.4 Global Immunotherapy Products Market Concentration Ratio

3.4.1 Global Immunotherapy Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Products Revenue in 2025

3.5 Global Key Players of Immunotherapy Products Head Offices and Areas Served

3.6 Global Key Players of Immunotherapy Products, Products and Applications

3.7 Global Key Players of Immunotherapy Products, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Immunotherapy Products Breakdown Data by Type

4.1 Global Immunotherapy Products Historic Market Size by Type (2021–2026)

4.2 Global Immunotherapy Products Forecasted Market Size by Type (2027–2032)

5 Immunotherapy Products Breakdown Data by Application

5.1 Global Immunotherapy Products Historic Market Size by Application (2021–2026)

5.2 Global Immunotherapy Products Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Immunotherapy Products Market Size (2021–2032)

6.2 North America Immunotherapy Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Immunotherapy Products Market Size by Country (2021–2026)

6.4 North America Immunotherapy Products Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immunotherapy Products Market Size (2021–2032)

7.2 Europe Immunotherapy Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Immunotherapy Products Market Size by Country (2021–2026)

7.4 Europe Immunotherapy Products Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Immunotherapy Products Market Size (2021–2032)

8.2 Asia-Pacific Immunotherapy Products Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Immunotherapy Products Market Size by Region (2021–2026)

8.4 Asia-Pacific Immunotherapy Products Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Immunotherapy Products Market Size (2021–2032)

9.2 Latin America Immunotherapy Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Immunotherapy Products Market Size by Country (2021–2026)

9.4 Latin America Immunotherapy Products Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immunotherapy Products Market Size (2021–2032)

10.2 Middle East & Africa Immunotherapy Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Immunotherapy Products Market Size by Country (2021–2026)

10.4 Middle East & Africa Immunotherapy Products Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Details

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Immunotherapy Products Introduction

11.1.4 Johnson & Johnson Revenue in Immunotherapy Products Business (2021–2026)

11.1.5 Johnson & Johnson Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Immunotherapy Products Introduction

11.2.4 Roche Revenue in Immunotherapy Products Business (2021–2026)

11.2.5 Roche Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Immunotherapy Products Introduction

11.3.4 Pfizer Revenue in Immunotherapy Products Business (2021–2026)

11.3.5 Pfizer Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Immunotherapy Products Introduction

11.4.4 Merck Revenue in Immunotherapy Products Business (2021–2026)

11.4.5 Merck Recent Development

11.5 AbbVie

11.5.1 AbbVie Company Details

11.5.2 AbbVie Business Overview

11.5.3 AbbVie Immunotherapy Products Introduction

11.5.4 AbbVie Revenue in Immunotherapy Products Business (2021–2026)

11.5.5 AbbVie Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Immunotherapy Products Introduction

11.6.4 Novartis Revenue in Immunotherapy Products Business (2021–2026)

11.6.5 Novartis Recent Development

11.7 Bristol Myers Squibb

11.7.1 Bristol Myers Squibb Company Details

11.7.2 Bristol Myers Squibb Business Overview

11.7.3 Bristol Myers Squibb Immunotherapy Products Introduction

11.7.4 Bristol Myers Squibb Revenue in Immunotherapy Products Business (2021–2026)

11.7.5 Bristol Myers Squibb Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Immunotherapy Products Introduction

11.8.4 Sanofi Revenue in Immunotherapy Products Business (2021–2026)

11.8.5 Sanofi Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Details

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Immunotherapy Products Introduction

11.9.4 AstraZeneca Revenue in Immunotherapy Products Business (2021–2026)

11.9.5 AstraZeneca Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Immunotherapy Products Introduction

11.10.4 Takeda Revenue in Immunotherapy Products Business (2021–2026)

11.10.5 Takeda Recent Development

11.11 Amgen

11.11.1 Amgen Company Details

11.11.2 Amgen Business Overview

11.11.3 Amgen Immunotherapy Products Introduction

11.11.4 Amgen Revenue in Immunotherapy Products Business (2021–2026)

11.11.5 Amgen Recent Development

11.12 Eli Lilly

11.12.1 Eli Lilly Company Details

11.12.2 Eli Lilly Business Overview

11.12.3 Eli Lilly Immunotherapy Products Introduction

11.12.4 Eli Lilly Revenue in Immunotherapy Products Business (2021–2026)

11.12.5 Eli Lilly Recent Development

11.13 Gilead Sciences

11.13.1 Gilead Sciences Company Details

11.13.2 Gilead Sciences Business Overview

11.13.3 Gilead Sciences Immunotherapy Products Introduction

11.13.4 Gilead Sciences Revenue in Immunotherapy Products Business (2021–2026)

11.13.5 Gilead Sciences Recent Development

11.14 Novo Nordisk

11.14.1 Novo Nordisk Company Details

11.14.2 Novo Nordisk Business Overview

11.14.3 Novo Nordisk Immunotherapy Products Introduction

11.14.4 Novo Nordisk Revenue in Immunotherapy Products Business (2021–2026)

11.14.5 Novo Nordisk Recent Development

11.15 GlaxoSmithKline

11.15.1 GlaxoSmithKline Company Details

11.15.2 GlaxoSmithKline Business Overview

11.15.3 GlaxoSmithKline Immunotherapy Products Introduction

11.15.4 GlaxoSmithKline Revenue in Immunotherapy Products Business (2021–2026)

11.15.5 GlaxoSmithKline Recent Development

11.16 CSL

11.16.1 CSL Company Details

11.16.2 CSL Business Overview

11.16.3 CSL Immunotherapy Products Introduction

11.16.4 CSL Revenue in Immunotherapy Products Business (2021–2026)

11.16.5 CSL Recent Development

11.17 UCB

11.17.1 UCB Company Details

11.17.2 UCB Business Overview

11.17.3 UCB Immunotherapy Products Introduction

11.17.4 UCB Revenue in Immunotherapy Products Business (2021–2026)

11.17.5 UCB Recent Development

11.18 Moderna

11.18.1 Moderna Company Details

11.18.2 Moderna Business Overview

11.18.3 Moderna Immunotherapy Products Introduction

11.18.4 Moderna Revenue in Immunotherapy Products Business (2021–2026)

11.18.5 Moderna Recent Development

11.19 BioNTech

11.19.1 BioNTech Company Details

11.19.2 BioNTech Business Overview

11.19.3 BioNTech Immunotherapy Products Introduction

11.19.4 BioNTech Revenue in Immunotherapy Products Business (2021–2026)

11.19.5 BioNTech Recent Development

11.20 BeiGene

11.20.1 BeiGene Company Details

11.20.2 BeiGene Business Overview

11.20.3 BeiGene Immunotherapy Products Introduction

11.20.4 BeiGene Revenue in Immunotherapy Products Business (2021–2026)

11.20.5 BeiGene Recent Development

11.21 Innovent Biologics

11.21.1 Innovent Biologics Company Details

11.21.2 Innovent Biologics Business Overview

11.21.3 Innovent Biologics Immunotherapy Products Introduction

11.21.4 Innovent Biologics Revenue in Immunotherapy Products Business (2021–2026)

11.21.5 Innovent Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Immunotherapy Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Therapeutic and Prophylactic Vaccines

Table 3. Key Players of Cell Therapy

Table 4. Key Players of Antibody Therapeutics

Table 5. Key Players of Antibody-Drug Conjugates

Table 6. Key Players of Peptide Therapeutics and Peptide Conjugates

Table 7. Key Players of Immunomodulators

Table 8. Global Immunotherapy Products Market Size Growth Rate by Mode (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Immune-Activating Interventions

Table 10. Key Players of Immune-Suppressive / Immune-Tolerant Interventions

Table 11. Key Players of Immune Reconstitution and Balancing Interventions

Table 12. Global Immunotherapy Products Market Size Growth Rate by Diseases (US$ Million): 2021 vs 2025 vs 2032

Table 13. Key Players of Oncology

Table 14. Key Players of Autoimmune and Inflammatory Diseases

Table 15. Key Players of Infectious Disease Prevention and Treatment

Table 16. Key Players of Other

Table 17. Global Immunotherapy Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Immunotherapy Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Immunotherapy Products Market Size by Region (US$ Million), 2021–2026

Table 20. Global Immunotherapy Products Market Share by Region (2021–2026)

Table 21. Global Immunotherapy Products Forecasted Market Size by Region (US$ Million), 2027–2032

Table 22. Global Immunotherapy Products Market Share by Region (2027–2032)

Table 23. Immunotherapy Products Market Trends

Table 24. Immunotherapy Products Market Drivers

Table 25. Immunotherapy Products Market Challenges

Table 26. Immunotherapy Products Market Restraints

Table 27. Global Immunotherapy Products Revenue by Players (US$ Million), 2021–2026

Table 28. Global Immunotherapy Products Market Share by Players (2021–2026)

Table 29. Global Top Immunotherapy Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on Immunotherapy Products Revenue, 2025

Table 30. Ranking of Global Top Immunotherapy Products Companies by Revenue (US$ Million) in 2025

Table 31. Global 5 Largest Players Market Share by Immunotherapy Products Revenue (CR5 and HHI), 2021–2026

Table 32. Global Key Players of Immunotherapy Products, Headquarters and Area Served

Table 33. Global Key Players of Immunotherapy Products, Products and Applications

Table 34. Global Key Players of Immunotherapy Products, Date of General Availability (GA)

Table 35. Mergers and Acquisitions, Expansion Plans

Table 36. Global Immunotherapy Products Market Size by Type (US$ Million), 2021–2026

Table 37. Global Immunotherapy Products Revenue Market Share by Type (2021–2026)

Table 38. Global Immunotherapy Products Forecasted Market Size by Type (US$ Million), 2027–2032

Table 39. Global Immunotherapy Products Revenue Market Share by Type (2027–2032)

Table 40. Global Immunotherapy Products Market Size by Application (US$ Million), 2021–2026

Table 41. Global Immunotherapy Products Revenue Market Share by Application (2021–2026)

Table 42. Global Immunotherapy Products Forecasted Market Size by Application (US$ Million), 2027–2032

Table 43. Global Immunotherapy Products Revenue Market Share by Application (2027–2032)

Table 44. North America Immunotherapy Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. North America Immunotherapy Products Market Size by Country (US$ Million), 2021–2026

Table 46. North America Immunotherapy Products Market Size by Country (US$ Million), 2027–2032

Table 47. Europe Immunotherapy Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 48. Europe Immunotherapy Products Market Size by Country (US$ Million), 2021–2026

Table 49. Europe Immunotherapy Products Market Size by Country (US$ Million), 2027–2032

Table 50. Asia-Pacific Immunotherapy Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 51. Asia-Pacific Immunotherapy Products Market Size by Region (US$ Million), 2021–2026

Table 52. Asia-Pacific Immunotherapy Products Market Size by Region (US$ Million), 2027–2032

Table 53. Latin America Immunotherapy Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 54. Latin America Immunotherapy Products Market Size by Country (US$ Million), 2021–2026

Table 55. Latin America Immunotherapy Products Market Size by Country (US$ Million), 2027–2032

Table 56. Middle East & Africa Immunotherapy Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 57. Middle East & Africa Immunotherapy Products Market Size by Country (US$ Million), 2021–2026

Table 58. Middle East & Africa Immunotherapy Products Market Size by Country (US$ Million), 2027–2032

Table 59. Johnson & Johnson Company Details

Table 60. Johnson & Johnson Business Overview

Table 61. Johnson & Johnson Immunotherapy Products Product

Table 62. Johnson & Johnson Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 63. Johnson & Johnson Recent Development

Table 64. Roche Company Details

Table 65. Roche Business Overview

Table 66. Roche Immunotherapy Products Product

Table 67. Roche Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 68. Roche Recent Development

Table 69. Pfizer Company Details

Table 70. Pfizer Business Overview

Table 71. Pfizer Immunotherapy Products Product

Table 72. Pfizer Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 73. Pfizer Recent Development

Table 74. Merck Company Details

Table 75. Merck Business Overview

Table 76. Merck Immunotherapy Products Product

Table 77. Merck Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 78. Merck Recent Development

Table 79. AbbVie Company Details

Table 80. AbbVie Business Overview

Table 81. AbbVie Immunotherapy Products Product

Table 82. AbbVie Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 83. AbbVie Recent Development

Table 84. Novartis Company Details

Table 85. Novartis Business Overview

Table 86. Novartis Immunotherapy Products Product

Table 87. Novartis Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 88. Novartis Recent Development

Table 89. Bristol Myers Squibb Company Details

Table 90. Bristol Myers Squibb Business Overview

Table 91. Bristol Myers Squibb Immunotherapy Products Product

Table 92. Bristol Myers Squibb Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 93. Bristol Myers Squibb Recent Development

Table 94. Sanofi Company Details

Table 95. Sanofi Business Overview

Table 96. Sanofi Immunotherapy Products Product

Table 97. Sanofi Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 98. Sanofi Recent Development

Table 99. AstraZeneca Company Details

Table 100. AstraZeneca Business Overview

Table 101. AstraZeneca Immunotherapy Products Product

Table 102. AstraZeneca Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 103. AstraZeneca Recent Development

Table 104. Takeda Company Details

Table 105. Takeda Business Overview

Table 106. Takeda Immunotherapy Products Product

Table 107. Takeda Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 108. Takeda Recent Development

Table 109. Amgen Company Details

Table 110. Amgen Business Overview

Table 111. Amgen Immunotherapy Products Product

Table 112. Amgen Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 113. Amgen Recent Development

Table 114. Eli Lilly Company Details

Table 115. Eli Lilly Business Overview

Table 116. Eli Lilly Immunotherapy Products Product

Table 117. Eli Lilly Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 118. Eli Lilly Recent Development

Table 119. Gilead Sciences Company Details

Table 120. Gilead Sciences Business Overview

Table 121. Gilead Sciences Immunotherapy Products Product

Table 122. Gilead Sciences Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 123. Gilead Sciences Recent Development

Table 124. Novo Nordisk Company Details

Table 125. Novo Nordisk Business Overview

Table 126. Novo Nordisk Immunotherapy Products Product

Table 127. Novo Nordisk Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 128. Novo Nordisk Recent Development

Table 129. GlaxoSmithKline Company Details

Table 130. GlaxoSmithKline Business Overview

Table 131. GlaxoSmithKline Immunotherapy Products Product

Table 132. GlaxoSmithKline Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 133. GlaxoSmithKline Recent Development

Table 134. CSL Company Details

Table 135. CSL Business Overview

Table 136. CSL Immunotherapy Products Product

Table 137. CSL Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 138. CSL Recent Development

Table 139. UCB Company Details

Table 140. UCB Business Overview

Table 141. UCB Immunotherapy Products Product

Table 142. UCB Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 143. UCB Recent Development

Table 144. Moderna Company Details

Table 145. Moderna Business Overview

Table 146. Moderna Immunotherapy Products Product

Table 147. Moderna Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 148. Moderna Recent Development

Table 149. BioNTech Company Details

Table 150. BioNTech Business Overview

Table 151. BioNTech Immunotherapy Products Product

Table 152. BioNTech Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 153. BioNTech Recent Development

Table 154. BeiGene Company Details

Table 155. BeiGene Business Overview

Table 156. BeiGene Immunotherapy Products Product

Table 157. BeiGene Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 158. BeiGene Recent Development

Table 159. Innovent Biologics Company Details

Table 160. Innovent Biologics Business Overview

Table 161. Innovent Biologics Immunotherapy Products Product

Table 162. Innovent Biologics Revenue in Immunotherapy Products Business (US$ Million), 2021–2026

Table 163. Innovent Biologics Recent Development

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

Table 167. Authors List of This Report

List of Figures

Figure 1. Immunotherapy Products Picture

Figure 2. Global Immunotherapy Products Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Immunotherapy Products Market Share by Type: 2025 vs 2032

Figure 4. Therapeutic and Prophylactic Vaccines Features

Figure 5. Cell Therapy Features

Figure 6. Antibody Therapeutics Features

Figure 7. Antibody-Drug Conjugates Features

Figure 8. Peptide Therapeutics and Peptide Conjugates Features

Figure 9. Immunomodulators Features

Figure 10. Global Immunotherapy Products Market Size Comparison by Mode (US$ Million), 2021–2032

Figure 11. Immune-Activating Interventions Features

Figure 12. Immune-Suppressive / Immune-Tolerant Interventions Features

Figure 13. Immune Reconstitution and Balancing Interventions Features

Figure 14. Global Immunotherapy Products Market Size Comparison by Diseases (US$ Million), 2021–2032

Figure 15. Oncology Features

Figure 16. Autoimmune and Inflammatory Diseases Features

Figure 17. Infectious Disease Prevention and Treatment Features

Figure 18. Other Features

Figure 19. Global Immunotherapy Products Market Size by Application (US$ Million), 2021–2032

Figure 20. Global Immunotherapy Products Market Share by Application: 2025 vs 2032

Figure 21. Hospitals and Clinical Healthcare Institutions Case Studies

Figure 22. Research Institutes and Academic Laboratories Case Studies

Figure 23. Biopharmaceutical and Biotechnology Companies Case Studies

Figure 24. Other Case Studies

Figure 25. Immunotherapy Products Report Years Considered

Figure 26. Global Immunotherapy Products Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 27. Global Immunotherapy Products Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 28. Global Immunotherapy Products Market Share by Region: 2025 vs 2032

Figure 29. Global Immunotherapy Products Market Share by Players in 2025

Figure 30. Global Immunotherapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 31. The Top 10 and 5 Players Market Share by Immunotherapy Products Revenue in 2025

Figure 32. North America Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. North America Immunotherapy Products Market Share by Country (2021–2032)

Figure 34. United States Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Canada Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Europe Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Europe Immunotherapy Products Market Share by Country (2021–2032)

Figure 38. Germany Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. France Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. U.K. Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Italy Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Russia Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Ireland Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Asia-Pacific Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Asia-Pacific Immunotherapy Products Market Share by Region (2021–2032)

Figure 46. China Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Japan Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. South Korea Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Southeast Asia Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. India Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Australia & New Zealand Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Latin America Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Latin America Immunotherapy Products Market Share by Country (2021–2032)

Figure 54. Mexico Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Brazil Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Middle East & Africa Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Middle East & Africa Immunotherapy Products Market Share by Country (2021–2032)

Figure 58. Israel Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. Saudi Arabia Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 60. UAE Immunotherapy Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 61. Johnson & Johnson Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 62. Roche Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 63. Pfizer Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 64. Merck Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 65. AbbVie Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 66. Novartis Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 67. Bristol Myers Squibb Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 68. Sanofi Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 69. AstraZeneca Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 70. Takeda Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 71. Amgen Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 72. Eli Lilly Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 73. Gilead Sciences Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 74. Novo Nordisk Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 75. GlaxoSmithKline Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 76. CSL Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 77. UCB Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 78. Moderna Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 79. BioNTech Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 80. BeiGene Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 81. Innovent Biologics Revenue Growth Rate in Immunotherapy Products Business (2021–2026)

Figure 82. Bottom-up and Top-down Approaches for This Report

Figure 83. Data Triangulation

Figure 84. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Immunotherapy Products Market Research Report 2026

Published Date: 2026-01-28

Report Code: QYRE-Auto-7C20368

Global Immunotherapy Products Market Research Report 2026

FEATURED COMPANIES

Immunotherapy Products Market Size

Immunotherapy Products Market

Scope of Immunotherapy Products Market Report

Chapter Outline

FAQ for this report

How fast is Immunotherapy Products Market growing?

What is the Immunotherapy Products Market size in 2032?

Who are the main players in the Immunotherapy Products Market report?

What are the Application segmentation covered in the Immunotherapy Products Market report?

What are the Type segmentation covered in the Immunotherapy Products Market report?

FEATURED COMPANIES